Young Amber M, Audus Kenneth L, Proudfoot John, Yazdanian Mehran
Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas, USA.
J Pharm Sci. 2006 Apr;95(4):717-25. doi: 10.1002/jps.20526.
A tetrazole ring is often used in drug discovery as a replacement for the carboxylic acid group. Previous work indicates that compounds containing a tetrazole moiety show asymmetric permeability in Caco-2 cells characteristic of an efflux transporter substrate. The aim of this study is to determine which transporters are responsible for polarization of transport of tetrazole-containing compounds in Caco-2 cells. Results indicate that only select compounds with tetrazole moieties display asymmetric transport. Three compounds (two commercial drug products and one druglike structure) were selected for further studies. Losartan appears to be primarily a P-glycoprotein (P-gp) substrate, as previously reported, but MRP inhibitors such as MK-571 and rifampicin also affect the difference between apical to basolateral and basolateral to apical transport. Pemirolast and phenyltetrazole derivative C are sensitive to P-gp inhibition, but transport seems to be mediated by one or more of the MRP family of transporters. Additionally, lowering the pH from 7.4 to 4.0 eliminates the polarization of permeability in Caco-2 cells. These studies indicate that some tetrazole compounds are susceptible to efflux, therefore caution should be used when choosing an appropriate functional group to replace carboxylic acids when synthesizing a drug candidate.
四氮唑环在药物研发中常被用作羧酸基团的替代物。先前的研究表明,含有四氮唑部分的化合物在Caco-2细胞中表现出不对称渗透性,这是外排转运体底物的特征。本研究的目的是确定哪些转运体负责含四氮唑化合物在Caco-2细胞中的转运极化。结果表明,只有特定的含四氮唑部分的化合物表现出不对称转运。选择了三种化合物(两种市售药品和一种类药结构)进行进一步研究。如先前报道,氯沙坦似乎主要是P-糖蛋白(P-gp)底物,但MK-571和利福平之类的多药耐药相关蛋白(MRP)抑制剂也会影响从顶端到基底外侧以及从基底外侧到顶端转运的差异。吡嘧司特和苯基四氮唑衍生物C对P-gp抑制敏感,但转运似乎由一种或多种MRP家族转运体介导。此外,将pH从7.4降至4.0可消除Caco-2细胞中渗透性的极化。这些研究表明,一些四氮唑化合物易受外排影响,因此在合成候选药物时选择合适的官能团来替代羧酸时应谨慎。